Correlation Between Programmed Death-1 (PD-1) Expression in Tumor Infiltrating Lymphocytes and Programmed Death Ligand-1 (PD-L1) Expression in Non-Small Cell Lung Carcinoma

被引：0
|
作者：
Driver, Brandon
Miller, Ross A.
Deavers, Michael
Tacha, David
Bernicker, Eric
Cagle, Philip T.
机构：
[1] Houston Methodist Hosp, Houston, TX USA
[2] Biocare Med LLC, Concord, CA USA
来源：
LABORATORY INVESTIGATION | 2017年 / 97卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
1913
引用
收藏
页码：475A / 475A
页数：1
相关论文
共 50 条
  • [21] Circulating programmed death ligand-1 (PD-L1) in non-small cell lung cancer (NSCLC)
    Vecchiarelli, S.
    D'Incecco, A.
    Gallo, M.
    De Luca, A.
    Minuti, G.
    Landi, L.
    Bennati, C.
    Spreafico, M.
    D'Arcangelo, M.
    Attilia, L.
    Mazza, V.
    Normanno, N.
    Cappuzzo, F.
    ANNALS OF ONCOLOGY, 2017, 28
  • [22] TUMOR INFILTRATING LYMPHOCYTES AND PROGRAMMED DEATH LIGAND 1 (PD-L1) EXPRESSION IN DIFFUSE AND ANAPLASTIC GLIOMAS
    Berghoff, A. S.
    Kiesel, B.
    Widhalm, G.
    Wilhelm, D.
    Rajky, O.
    Kurscheid, S.
    Hegi, M.
    Woehrer, A.
    Marosi, C.
    Preusser, M.
    NEURO-ONCOLOGY, 2016, 18 : 26 - 26
  • [23] Programmed death ligand 1 (PD-L1) expression and tumor infiltrating lymphocytes in diffuse and anaplastic gliomas
    Berghoff, A. S.
    Kiesel, B.
    Widhalm, G.
    Rajky, O.
    Ricken, G.
    Woehrer, A.
    Dieckmann, K.
    Zielinski, C. C.
    Marosi, C.
    Preusser, M.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S593 - S593
  • [24] Programmed death ligand-1 (PD-L1) heterogeneity in non-small cell lung cancer (NSCLC)
    McLaughlin, Joseph
    Schalper, Kurt A.
    Carvajal-Hausdorf, Daniel E.
    Pelekanou, Vasiliki
    Velcheti, Vamsidhar
    Haack, Herbert
    Silver, Matthew R.
    Herbst, Roy
    LoRusso, Patricia
    Rimm, David L.
    CANCER RESEARCH, 2015, 75
  • [25] Programmed death-1 (PD-1) receptor/PD-1 ligand (PD-L1) expression in fumarate hydratase-deficient renal cell carcinoma
    Alaghehbandan, Reza
    Stehlik, Jan
    Trpkov, Kiril
    Magi-Galluzzi, Cristina
    Mundo, Enric Condom
    Foix, Maria Pane
    Berney, Daniel
    Sibony, Mathilde
    Suster, Saul
    Agaimy, Abbas
    Montiel, Delia Perez
    Pivovarcikova, Kristyna
    Michalova, Kvetoslava
    Daum, Ondrej
    Ondic, Ondrej
    Rotterova, Pavla
    Dusek, Martin
    Hora, Milan
    Michal, Michal
    Hes, Ondrej
    ANNALS OF DIAGNOSTIC PATHOLOGY, 2017, 29 : 17 - 22
  • [26] Association Between Programmed Death Ligand-1 (PD-L1) Expression and Clinicopathological Features in Non-small Cell Lung Cancer (NSCLC)
    Valcarcel Gonzalez, S.
    Diaz, P.
    Villanueva Palicio, N.
    Alvarez Fernandez, C.
    Contreras Toledo, D. C.
    Mihic Gongora, L.
    Rodriguez Gonzalez, A.
    Velasco Durantez, V.
    Solis Hernandez, M. D. P.
    Esteban Gonzalez, E.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S569 - S570
  • [27] Prognostic Impact of Programmed Cell Death-1 (PD-1) and PD-Ligand 1 (PD-L1) Expression in Thymic Cancer
    Funaki, S.
    Shintani, Y.
    Ose, N.
    Kawamura, T.
    Kanzaki, R.
    Minami, M.
    Okumura, M.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2064 - S2065
  • [28] Correlation of programmed Death Ligand-1 (PD-L1) expression with clinicopathological features in lung carcinoma in a Macedonian population
    Ognenoska-Jankovska, B.
    Basheska, N.
    VIRCHOWS ARCHIV, 2022, 481 (SUPPL 1) : S335 - S335
  • [29] In vitro Interactions of Chicken Programmed Cell Death 1 (PD-1) and PD-1 Ligand-1 (PD-L1)
    Reddy, Vishwanatha R. A. P.
    Mwangi, William
    Sadigh, Yashar
    Nair, Venugopal
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2019, 9
  • [30] Programmed death ligand-1 (PD-L1) expression in non-small cell lung cancer (NSCLC), results of a single institution
    Slezak, A.
    Toth, E.
    VIRCHOWS ARCHIV, 2018, 473 : S112 - S112
12345